IntoCell and Ab Studio to Start Research Collaboration

DAEJEON, South Korea, and HAYWARD, Calif.: DAEJEON, South Korea, and HAYWARD, Calif., Oct. 14, 2021 /PRNewswire/ -- IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the signing of a research collaboration with Ab Studio, a US biotech focused on the discovery of novel...

Click to view original post